Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Pasithea Therapeutics Corp (KTTA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Pasithea Therapeutics's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
7.050 +0.100    +1.44%
03/05 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 172
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 6.950 - 7.170
Pasithea Therapeutics 7.050 +0.100 +1.44%

KTTA Ratios

 
Assess the performance of Pasithea Therapeutics (KTTA). This table contains core financial ratios such as Price-to-Earnings (P/E ratio), Return-On-Investment (ROI), Earnings per share (EPS), Dividend yield and others based on Pasithea Therapeutics Corp's latest financial reports. Compare the performance metrics of Pasithea Therapeutics (KTTA) against the industry averages.
InvestingPro Advanced Ratios
Name Company Industry
   
P/E Ratio TTM -0.47 1.19
Price to Sales TTM - 155.35
Price to Cash Flow MRQ -0.54 9.95
Price to Free Cash Flow TTM -0.54 8.23
Price to Book MRQ 0.31 1.35
Price to Tangible Book MRQ 0.51 -6.75
   
Profitability: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Gross margin TTM - -736.94
Gross Margin 5YA 24.49% -583.73
Operating margin TTM 0% -1,956.69
Operating margin 5YA -28,948.31% -2,118.13
Pretax margin TTM 0% -2,067.42
Pretax margin 5YA -17,130.58% -528.09
Net Profit margin TTM 0% -2,059.48
Net Profit margin 5YA -19,162.47% -4,261.91
   
Revenue/Share TTM - 39.76
Basic EPS ANN -13.01 6.07
Diluted EPS ANN -13.01 5.75
Book Value/Share MRQ 22.46 65.8
Tangible Book Value/Share MRQ 13.63 48.75
Cash/Share MRQ 15.68 18.09
Cash Flow/Share TTM -12.89 9.91
   
Management Effectiveness: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Return on Equity TTM -47.07% -80.67
Return on Equity 5YA -22.6% -63.78
Return on Assets TTM -44.78% -13.24
Return on Assets 5YA -27.45% -10.74
Return on Investment TTM -41.34% -6.59
Return on Investment 5YA -28.48% -6.33
   
EPS(MRQ) vs Qtr. 1 Yr. Ago MRQ 0% 1.85
EPS(TTM) vs TTM 1 Yr. Ago TTM -17.87% 257.3
5 Year EPS Growth 5YA 0% 7.22
Sales (MRQ) vs Qtr. 1 Yr. Ago MRQ 0% 17,802.57
Sales (TTM) vs TTM 1 Yr. Ago TTM 0% 205.95
5 Year Sales Growth 5YA 0% 29.87
5 Year Capital Spending Growth 5YA 0% 17.64
   
Quick Ratio MRQ 6.2 5.83
Current Ratio MRQ 6.34 6.3
LT Debt to Equity MRQ - 52.77
Total Debt to Equity MRQ 0.35% 26.54
Efficiency    
Asset Turnover TTM - 0.33
Inventory Turnover TTM - 5.32
Revenue/Employee TTM - 803.31K
Net Income/Employee TTM -2.00M -276.87K
Receivable Turnover TTM - 7.37
   
Dividend Yield ANN - 0.04
Dividend Yield 5 Year Avg. 5YA - 0.03
Dividend Growth Rate ANN 0% 1.02
Payout Ratio TTM - 2.02
TTM = Trailing Twelve Months  5YA = 5-Year Average  MRQ = Most Recent Quarter
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced valuation and financial ratios for in-depth analysis of company financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

KTTA Comments

Write your thoughts about Pasithea Therapeutics Corp
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Val Stevens
Val Stevens Feb 11, 2022 12:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
KTTA upside surprise move coming:https://www.benzinga.com/news/22/02/25390881/exclusive-pasithea-therapeutics-initiates-new-chemical-entity-drug-development-program-in-multiple-s
anthony jones
anthony jones Feb 02, 2022 9:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
soon
MIKHAIL KUZNETSOV
MIKHAIL KUZNETSOV Jan 30, 2022 7:19AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
A little patience and we'll see a bomb here , I bought this miracle at a price of $ 1.10 , I don't think we 'll be sitting here for long .
Vlas Dacian
Vlas Dacian Nov 23, 2021 10:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
When only the big guys can short stay away … this will drop in the same style
Batuhan Babür
Batuhan Babür Nov 23, 2021 8:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Next LGVN?
Abid Ikram
Abid Ikram Nov 03, 2021 8:56AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Next year can be quite good for stock NCNA and my target buying price is b/w 1.9 - 2.1
Abid Ikram
Abid Ikram Nov 03, 2021 8:53AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
My target buying price will be $ 1.7 to keep it for long term until it reach to $5 to $10
Batuhan Babür
Batuhan Babür Oct 27, 2021 1:27PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Trash stock
Batuhan Babür
Batuhan Babür Oct 27, 2021 1:16PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I hope all these shorts burn
Batuhan Babür
Batuhan Babür Oct 27, 2021 1:00PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Go 4+ who is selling at these levels man its already bottom
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email